【train from meriden to new haven】Does Cosmo Pharmaceuticals N.V.’s (VTX:COPN) CEO Salary Compare Well With Others?
Alessandro Della Chà became the CEO of Cosmo Pharmaceuticals N.V. (
VTX:COPN
) in 2014. This train from meriden to new havenanalysis aims first to contrast CEO compensation with other companies that have similar market capitalization. After that, we will consider the growth in the business. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO.
Check out our latest analysis for Cosmo Pharmaceuticals
How Does Alessandro Della Chà’s Compensation Compare With Similar Sized Companies?
At the time of writing our data says that Cosmo Pharmaceuticals N.V. has a market cap of CHF1.3b, and is paying total annual CEO compensation of €1.7m. (This figure is for the year to 2017). While we always look at total compensation first, we note that the salary component is less, at €30k. When we examined a selection of companies with market caps ranging from €874m to €2.8b, we found the median CEO compensation was €1.5m.
That means Alessandro Della Chà receives fairly typical remuneration for the CEO of a company that size. While this data point isn’t particularly informative alone, it gains more meaning when considered with business performance.
You can see, below, how CEO compensation at Cosmo Pharmaceuticals has changed over time.
SWX:COPN CEO Compensation January 1st 19
Is Cosmo Pharmaceuticals N.V. Growing?
Over the last three years Cosmo Pharmaceuticals N.V. has shrunk its earnings per share by an average of 126% per year. In the last year, its revenue is up 5.3%.
Few shareholders would be pleased to read that earnings per share are lower over three years. The fairly low revenue growth fails to impress given that the earnings per share is down. It’s hard to argue the company is firing on all cylinders, so shareholders might be averse to high CEO remuneration.
Shareholders might be interested in
this
free
visualization of analyst forecasts.
.
Has Cosmo Pharmaceuticals N.V. Been A Good Investment?
With a three year total loss of 44%, Cosmo Pharmaceuticals N.V. would certainly have some dissatisfied shareholders. So shareholders would probably think the company shouldn’t be too generous with CEO compensation.
In Summary…
Alessandro Della Chà is paid around the same as most CEOs of similar size companies.
The company isn’t growing EPS, and shareholder returns have been disappointing. Suffice it to say, we don’t think the CEO is underpaid! If you think CEO compensation levels are interesting you will probably really like
this free visualization of insider trading at Cosmo Pharmaceuticals.
Story continues
Of course,
the past can be informative
so you might be interested in considering
this
analytical visualization
showing the company history of earnings and revenue
.
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at
.
View comments
(责任编辑:Exploration)
- Should Value Investors Buy Avis Budget Group (CAR) Stock?
- Deferred Interest, Waived Interest -- Why You Need to Know the Terms of Your 0% APR Offer
- Before You Buy China Soft Power Technology Holdings Limited (HKG:139), Consider Its Volatility
- Kim Kardashian's Met Gala After Party Was a Slice of Pizza and a Hotel Room Photo Shoot
- Rohingya must have choice on going to Bangladesh island - UN refugee agency
- iRhythm Technologies, Inc. Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
- Google Exec: The Phones We're Making At Motorola Aren't Going To 'Wow' You
- Galveston Attorney Charged With Representing Clients He'd Never Met
- Coke's Super Bowl ad mocked: Klingon, Dothraki added
- Vishay Precision Group, Inc. to Host Earnings Call
- Simulmedia Is First to Launch Guaranteed TV Ad Campaigns Using TRA's Purchase Data
- EU to send inspectors to Poland over suspect meat
- What Kind Of Shareholder Owns Most Shanshan Brand Management Co., Ltd. (HKG:1749) Stock?
-
U.S. SEC eases crowdfunding rules for firms due to coronavirus disruption
By Katanga JohnsonWASHINGTON, May 4 (Reuters) - The U.S. Securities and Exchange Commission (SEC) on ...[详细] -
China denies diplomat spied on Japan
BEIJING (AP) — China is denying spying allegations against one of its diplomats who left Japan this ...[详细] -
Nigeria's Kaduna refinery expected to resume by mid-April - NNPC
By Garba MuhammadKADUNA, Nigeria (Reuters) - Nigeria's 110,000 barrel per day refinery in the northe ...[详细] -
Should Stantec Inc. (TSE:STN) Focus On Improving This Fundamental Metric?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, th ...[详细] -
Ocean Shipping Services Continue To Deteriorate
It's getting even uglier out there in the ocean trades.Not only are "blank" (canceled) container-shi ...[详细] -
Mitsubishi Motors beats view with 38 percent profit jump on Southeast Asia sales
TOKYO (Reuters) - Mitsubishi Motors Corp reported a 38 percent jump in third-quarter operating profi ...[详细] -
Cargotec Corporation: SHARE REPURCHASE 2.1.2019
CARGOTEC CORPORATION ANNOUNCEMENT 2.1.2019SHARE REPURCHASE 2.1.2019In the Helsinki Stock ExchangeTra ...[详细] -
Burt Jenner Announces His Girlfriend Is Pregnant: 'So Happy I Can't See Straight'
The Kardashian-Jenner crew continues to grow!Burt Jennerannounced on Thursday that his girlfriendVal ...[详细] -
Stericycle (SRCL) Tops Q3 Earnings and Revenue Estimates
Stericycle (SRCL) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus E ...[详细] -
Hedge Funds Have Never Been This Bullish On TransDigm Group Incorporated (TDG)
Investing in small cap stocks has historically been a way to outperform the market, as small cap com ...[详细]
Oprah tour driving Weight Watchers memberships
BRIEF-Future Land Development Holdings Posts Jan Contracted Sales Of About RMB10,958 Mln
- Ramping up COVID-19 testing earlier would have helped the UK, top adviser says
- Is HKR International Limited’s (HKG:480) P/E Ratio Really That Good?
- Kim Kardashian's Met Gala After Party Was a Slice of Pizza and a Hotel Room Photo Shoot
- BRIEF-Royal China International Holdings Appoints Gao Jinyi Has As Executive Director
- Should Value Investors Buy Avis Budget Group (CAR) Stock?
- Porsche's Favorite Chronograph
- ‘FLTR’ ETF an Effective Countermove for Rising Rates